IGXT =MCap $33 M--FDA DECISION for Migraine Oral-f
Post# of 83
(Total Views: 488)
Posted On: 02/07/2020 1:41:34 PM
IGXT =MCap $33 M--FDA DECISION for Migraine Oral-film on March 26 and Launch of Cannabis Products by partner Tilray also expected during this Quarter = Stock could rallyyy to $1++ ahead of the FDA decision next month
Cannabis-Infused VersaFilm® Remains on Track for Commercial Launch in Q1-2020
IntelGenx Continues to Make Preparations Ahead of RIZAPORT® PDUFA Goal Date of March 26, 2020
Cannabis-Infused VersaFilm® Remains on Track for Commercial Launch in Q1-2020
IntelGenx Continues to Make Preparations Ahead of RIZAPORT® PDUFA Goal Date of March 26, 2020
(0)
(0)